Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression.

Sarah Pereira GomesSofia Rodrigues LimaFabio Gomes de Matos E SouzaLuísa Weber Bisol

Published in: Journal of psychopharmacology (Oxford, England) (2024)

The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.

Keyphrases

major depressive disorder
bipolar disorder
pain management
double blind
placebo controlled
clinical trial
case report
depressive symptoms
sleep quality
study protocol
phase iii
randomized controlled trial
phase ii
chronic pain
metabolic syndrome
insulin resistance
open label